Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia-Reference-Cited by-同舟云学术

Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

Author:

Hong Jihyung¹,Novick Diego¹,Montgomery William²,Moneta Maria Victoria³,Dueñas Héctor⁴,Peng Xiaomei⁵,Haro Josep Maria³

Affiliation:

1. Global Patient Outcomes and Real World Evidence (GPORWE); Eli Lilly and Company; Windlesham Surrey UK

2. Global Patient Outcomes and Real World Evidence (GPORWE); Eli Lilly Australia Pty Ltd; Sydney NSW Australia

3. Parc Sanitari Sant Joan de Déu; Fundació Sant Joan de Déu; CIBERSAM; Universitat de Barcelona; Barcelona Spain

4. EMBU Medical; Eli Lilly de Mexico; Mexico City US

5. Global Patient Outcomes and Real World Evidence (GPORWE); Eli Lilly and Company; Indianapolis IN US

Publisher

Wiley

Subject

Psychiatry and Mental health,General Medicine

Link

Reference37 articles.

1. Practice guideline for the treatment of patients with major depressive disorder (revision);American Psychiatric Association;Am J Psychiatry,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献